View More Recent Stories

Mar 4, 2025 05:05AM Citi Upgrades Charles River Labs (CRL) to Neutral
Mar 3, 2025 03:24AM Redburn-Atlantic Upgrades Charles River Labs (CRL) to Neutral
Feb 25, 2025 08:01AM Charles River Laboratories (CRL) Announces Agreement with Singapore General Hospital
Feb 19, 2025 12:33PM Charles River Labs (CRL) PT Lowered to $175 at Evercore ISI
Feb 19, 2025 07:01AM Charles River Laboratories (CRL) Tops Q4 EPS by 12c ; Offers Guidance
Jan 22, 2025 06:56AM William Blair Downgrades Charles River Labs (CRL) to Market Perform
Jan 21, 2025 10:33AM Charles River Labs (CRL) PT Lowered to $182 at TD Cowen
Jan 17, 2025 04:19AM UBS Downgrades Charles River Labs (CRL) to Neutral
Jan 15, 2025 05:16AM Charles River Labs (CRL) PT Lowered to $169 at Jefferies
Jan 14, 2025 09:39AM Citi Reiterates Sell Rating on Charles River Labs (CRL)
Jan 14, 2025 09:37AM JPMorgan Reiterates Neutral Rating on Charles River Labs (CRL)
Jan 14, 2025 09:35AM TD Cowen Reiterates Hold Rating on Charles River Labs (CRL)
Jan 14, 2025 09:35AM BofA Securities Reiterates Neutral Rating on Charles River Labs (CRL)
Jan 14, 2025 08:10AM Charles River Laboratories (CRL) expects 2025 revenue will decline organically in a similar range as estimated in 2024
Nov 25, 2024 07:29AM Charles River Labs (CRL) PT Lowered to $197 at Baird
Nov 11, 2024 08:39AM Charles River Labs (CRL) PT Raised to $227 at TD Cowen
Nov 7, 2024 07:14AM Charles River Labs (CRL) PT Raised to $211 at Baird
Nov 6, 2024 07:03AM Charles River Laboratories (CRL) Tops Q3 EPS by 17c, provides guidance
Oct 14, 2024 11:48AM Redburn-Atlantic Starts Charles River Labs (CRL) at Sell
Oct 7, 2024 05:33AM Evercore ISI Downgrades Charles River Labs (CRL) to In Line
Oct 1, 2024 05:36AM Citi Downgrades Charles River Labs (CRL) to Sell
Sep 17, 2024 08:02AM Charles River Laboratories (CRL) and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
Sep 17, 2024 06:48AM Mizuho Reiterates Neutral Rating on Charles River Labs (CRL)
Sep 4, 2024 08:06AM Charles River Laboratories (CRL) and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Aug 13, 2024 06:44AM Charles River Labs (CRL) PT Lowered to $210 at Mizuho
Aug 12, 2024 08:15AM Charles River Labs (CRL) PT Lowered to $203 at TD Cowen
Aug 8, 2024 05:55AM JPMorgan Downgrades Charles River Labs (CRL) to Neutral
Aug 8, 2024 03:05AM Baird Downgrades Charles River Labs (CRL) to Neutral
Aug 7, 2024 07:06AM Charles River Laboratories (CRL) Tops Q2 EPS by 40c; lowers guidance
Jul 30, 2024 08:04AM Charles River Laboratories (CRL) Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
Jul 24, 2024 08:03AM Charles River Laboratories (CRL) and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
Jul 15, 2024 02:00PM Life Science Tools & Diagnostics stocks: Q2 earnings preview
Jul 10, 2024 07:26AM Charles River Labs (CRL) PT Lowered to $239 at Baird
Jun 28, 2024 07:38AM Argus Downgrades Charles River Labs (CRL) to Hold, 'bearish pattern of lower highs and lower lows'
Jun 28, 2024 03:14AM Barclays Starts Charles River Labs (CRL) at Equalweight
Jun 13, 2024 06:28AM Charles River Labs (CRL) PT Raised to $271 at Baird
View More Recent Stories